Very early exposure to even a very small dose of herpes simplex virus (HSV) in infant mice can lead to cognitive decline later in life, according to findings from a new Dartmouth-led study, in ...

Very early exposure to even a very small dose of herpes simplex virus (HSV) in infant mice can lead to cognitive decline later in life, according to new findings. This is significant because of ...

EG 427 SAS has closed a €27 million (US$28.3 million) series B round, which will fund it to completion of the first clinical ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the ...

Very early exposure to even a very small dose of herpes simplex virus (HSV) in infant mice can lead to cognitive decline later in life, according to findings from a new Dartmouth-led study, in ...

Theralase® validates previous University of Manitoba research by demonstrating that Ruvidar TM is safe and effective in ...

From ancient remedies to modern natural treatments, discover proven solutions for fever blisters that actually work, ...

The overall market of herpes simplex is expected to boost with the expected launch of emerging therapy, increased awareness, and extensive research in the forecast period (2025-2034). LAS ...

Assembly Biosciences (ASMB) announced positive interim Phase 1a results in healthy participants from its ongoing Phase 1a/b study of ABI-1179, ...

University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of ...

Theralase® validates previous University of Manitoba research by demonstrating that Ruvidar TM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...

Genital herpes simplex virus (HSV) infections are frequently asymptomatic or undiagnosed, but more than half the US population is seropositive for HSV, and about one-fifth are positive for HSV-2.